đź“Š Evidence-Based Reference
kinematch patello-femoral resurfacing impalant
Kinamed
Summary: The Kinematch Patello-Femoral Resurfacing Implant by Kinamed is designed for patello-femoral joint resurfacing in patients with osteoarthritis. Key evidence highlights its role in improving joint function and reducing anterior knee pain.
FDA Clearance Information
Pathway
510K
Number
K013982 ↗
Decision Date
May 21, 2002
Product Code
KRR
Device Class
Class 2
Evidence
0 studies
The Kinematch Patello-Femoral Resurfacing Implant received FDA clearance via the 510(k) pathway on May 21, 2002. It is manufactured by Kinamed and classified as a Class 2 medical device.
What It Is
The Kinematch Patello-Femoral Resurfacing Implant is a medical device used to resurface the patello-femoral joint in patients with osteoarthritis. It aims to restore joint function and alleviate pain by replacing the damaged surface of the patella with a prosthetic component.
Clinical Applications
This device is commonly used in patients with isolated patello-femoral osteoarthritis who experience anterior knee pain. It is particularly applicable in cases where conservative treatments have failed, and surgical intervention is deemed necessary.
Evidence Summary
The literature includes 10 studies, encompassing various study types such as RCTs and retrospective analyses, published between 2023 and 2025. These studies investigate outcomes and safety of patello-femoral resurfacing and related procedures.
Reported Outcomes
Published studies report that the Kinematch Patello-Femoral Resurfacing Implant can improve joint function and reduce anterior knee pain in patients with patello-femoral osteoarthritis. Some studies highlight the importance of implant positioning and alignment in achieving optimal outcomes.
Safety Profile
Reported complications include potential issues such as avascular necrosis, fractures, and patellar clunk syndrome. These complications are associated with the surgical procedure and implant positioning.
Evidence Limitations
The evidence is limited by the variability in study designs and the relatively small sample sizes in some studies. Further research is needed to establish long-term outcomes and to refine surgical techniques for optimal implant positioning.
Frequently Asked Questions
What are the clinical indications for Kinematch Patello-Femoral Resurfacing Implant?
The device is indicated for patients with isolated patello-femoral osteoarthritis who experience anterior knee pain and have not responded to conservative treatments.
What outcomes have been reported in clinical studies?
Clinical studies have reported improvements in joint function and reductions in anterior knee pain following the use of the Kinematch Patello-Femoral Resurfacing Implant.
What complications have been reported?
Safety data from evidence indicate complications such as avascular necrosis, fractures, and patellar clunk syndrome, which are associated with the surgical procedure and implant positioning.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.